Multicenter case registration study of pulmonary hypertension with congenital heart disease
Not Applicable
Recruiting
- Conditions
- CHD-PAH (pulmonary arterial hypertension with congenital heart disease)
- Registration Number
- JPRN-UMIN000032366
- Lead Sponsor
- Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
1. A case planned to have cardiac surgery or catheter intervention within 6 months 2. A case performed cardiac surgery or catheter intervention within 6 months 3. A case with extremely unstable status 4. A case without informed consent 5. A case judged as inappropriate by principal investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link congenital heart disease to pulmonary arterial hypertension in the JPRN-UMIN000032366 observational study?
How does the JPRN-UMIN000032366 registry compare outcomes of CHD-PAH patients treated with endothelin receptor antagonists versus phosphodiesterase-5 inhibitors?
What biomarkers are being evaluated in the Tokyo Medical and Dental University multicenter study for predicting CHD-PAH progression and treatment response?
What adverse events are associated with PAH management in congenital heart disease patients enrolled in the JPRN-UMIN000032366 observational cohort?
What combination therapies are being explored for CHD-related pulmonary hypertension in the context of the JPRN-UMIN000032366 registry?